Budapest, Hungary

Bela Agai

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bela Agai. Retrieved from https://idiyas.com/inventor/bela-agai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bela Agai: Innovator in Pharmaceutical Processes

Introduction

Bela Agai is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug preparation. His work has implications for the creation of new therapeutic agents.

Latest Patents

Bela Agai holds 1 patent for a process related to the preparation of a specific compound. The patent details a method for synthesizing [4-(2-chloro-4-methoxy-5-methylphenyl)-5-methyl-thiazolo-2-yl]-[2-cyclopropyl-1-(3-fluoro-4-methylphenyl)-ethyl]-amine, as outlined in formula (I). This invention also includes new intermediates that are crucial for the preparation process.

Career Highlights

Agai is currently employed at Sanofi, a leading global healthcare company. His role involves research and development, where he applies his expertise in pharmaceutical chemistry to advance innovative solutions in drug formulation.

Collaborations

Throughout his career, Bela Agai has collaborated with esteemed colleagues, including Janos Fazekas and Peter Miskolczi. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Bela Agai's contributions to pharmaceutical innovation exemplify the impact of dedicated inventors in the healthcare industry. His work continues to influence the development of new therapeutic agents, showcasing the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…